225Ac-PSMA-I&T

Actinium-225 PSMA-I&T · Fusion Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 225Ac-PSMA-I&T, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST). [Phase 2]

See pricing